Notes
* Empfehlungsklassen gemäß Leitlinienmanual der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften und der Ärztlichen Zentralstelle Qualitätssicherung (http://www.dgsuchtmedizin.de/fix/leitlinien/aezq220.pdf).
Literatur
Alvarez F, Berg PA, Bianchi FB et al. (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938 (IV)
Batts KP, Ludwig J (1995) Chronic hepatitis—an update on terminology and reporting. Am J Surg Pathol 19:1409–1417 (IV)
Bedossa P, Poynard T for the METAVIR Cooperative Study Group (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289–293 (III)
Chevallier M, Guerret S, Chossegros P et al. (1994) A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20:349–355 (II b)
Conn HO (1991) Liver biopsy: increased risks in patients with cancer. Hepatology 14:206–209 (III)
Crawford AR, Lin XZ, Crawford JM (1998) The normal adult human liver biopsy: a quantitative reference standard. Hepatology 28:323–331 (II b)
De Groote J, Desmet V, Gedigk P et al. (1968) A classification of chronic hepatitis. Lancet ii:626–628
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513–1520 (IV)
Dienstag JL (2002) The role of liver biopsy in chronic hepatitis C. Hepatology 36:S152–S160 (IV)
Dries V, von Both I, Müller M et al. (1999) Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 29:223–229 (II b)
EASL International Consensus Conference on Hepatitis C (1999) Consensus statement. J Hepatol 30:956–961 (IV)
Gebo KA, Herlong HF, Torbenson MS et al. (2002) Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36:S161–S172 (III)
Goldin RD, Goldin JG, Burt AD et al. (1996) Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 25:649–654 (III)
Gordon SC, Veneri RJ, McFadden RF et al. (1991) Major hemorrhage after percutaneous liver biopsy in patients with AIDS. Gastroenterology 100:1787 (IV)
Grant, A, Neuberger J (1999) Guidelines on the use of liver biopsy in clinical practice. Gut 45 (Suppl IV):1–11 (IV)
Hopf U, Niederau C, Kleber G, Fleig WE (1997) Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 35:971–986 (IV)
Hederström E, Forsberg L, Florén CH, Prytz H (1989) Liver biopsy complications monitored by ultrasound. J Hepatol 8:94–98 (IV)
Ishak KG, Baptista A, Bianchi L et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699 (IV)
Knodell RG, Ishak KG, Black WC et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435
Marcellin P, Asselah T, Boyer N (2002) Fibrosis and disease progression in hepatitis C. Hepatology 36:S47–S56 (IV)
McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99:1396–1400 (II a)
Miniuk GY, Sutherland LR, Wiseman DA et al. (1987) Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bedrest after percutaneous liver biopsy. Gastroenterology 92:290–293 (I b)
National Institutes of Health consensus development conference statement (2002) Management of hepatitis C: 2002. Hepatology 36:S3–S20 (IV)
Özdogan M, Özgür O, Boyacioglu S et al. (1996) Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 74:442–444 (III)
Pradat P, Poynard T, Alberti A et al. (2002) Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology 36:973–977 (III)
Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165–173 (III)
Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374 (IV)
Terjung B, Lemnitzer I, Dumoulin FL et al. (2003) Bleeding complications after percutaneous liver biopsy: an analysis of risk factors. Digestion 67:138–145 (III)
The METAVIR Cooperative Group (1994) Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 20:15–20 (III)
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Additional information
(Literatur: Evidenzstärke gemäß Ärztliche Zentralstelle Qualitätssicherung in Klammern)
Für die Konsensusgruppe „Bioptische Diagnostik der chronischen Hepatitis“: Alle Autoren und Mitglieder der Konsensusgruppe sind am Ende der Publikation aufgeführt.
Mitglieder der Expertenkommission (alphabetisch):
Mitglieder der Expertenkommission (alphabetisch):
Rights and permissions
About this article
Cite this article
Schirmacher, P., Fleig, W.E., Tannapfel, A. et al. Bioptische Diagnostik der chronischen Hepatitis. Pathologe 25, 337–348 (2004). https://doi.org/10.1007/s00292-004-0692-7
Issue Date:
DOI: https://doi.org/10.1007/s00292-004-0692-7